Development of a Redox-Sensitive Spermine Prodrug for the Potential Treatment of Snyder Robinson Syndrome-Reference-Cited by-同舟云学术

Development of a Redox-Sensitive Spermine Prodrug for the Potential Treatment of Snyder Robinson Syndrome

Published:2021-10-25 Issue:21 Volume:64 Page:15593-15607
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Tantak Mukund P.¹,Sekhar Vandana¹,Tao Xianzun²,Zhai R. Grace²,Phanstiel Otto¹^ORCID

Affiliation:

1. Department of Medical Education, College of Medicine, University of Central Florida, 12722 Research Parkway, Orlando, Florida 32826-3227, United States

2. Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, 1600 NW 10th Ave, Miami, Florida 33136, United States

Funder

U.S. Department of Health and Human Services

Snyder Robinson Foundation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c00419

Reference44 articles.

1. Recessive Sex-Linked Mental Retardation in the Absence of Other Recognizable Abnormalities

2. X-linked spermine synthase gene (SMS) defect: the first polyamine deficiency syndrome